26-28 Flashcards

1
Q
  1. Congenital heart diseases
    - etiology
    - types
A
  • Environmental and genetic factors contribute to the development of congenital heart disease.
  • Congenital heart diseases are divided into two types; ​acyanotic and cyanotic​.
  • The left-to right shuts and obstructive stenotic lesions are acyanotic generally Oxygenated blood from the left heart (left atrium or left ventricle) or the aorta shunts to the right heart (right atrium or right ventricle) or the pulmonary artery through an opening or communication between the 2 sides.
  • while right to left shunts are cyanotic.
    Varying amounts of deoxygenated venous blood are shunted to the left heart (right-to-left shunt), reducing systemic arterial oxygen saturation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Acynotic Congenital heart diseases include:

A
  • ventricular septal defect
  • Arterial septal defect
  • patent ductus arteriosus
  • Endocardial cushion defect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cyanotic Congenital heart diseases include:

A
  • Tetralogy of Fallot
  • Transposition of the Great Arteries
  • Tricuspid atresia
  • Truncus Arteriosus
  • Total anomalous pulmonary venous return
  • Hypoplastic left heart syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

-Arterial septal defect

A

Atrial septal defect
ASDs represent 10% of all congenital heart defects, the most common being ​foramen ovale remaining open​. Some flow through the foramen ovale is normal just after birth, however it should usually close within a week for birth. ASDs are very rarely symptomatic, even in large shunts. A soft systolic ejection murmur can sometimes be detected, as can a fixed split S2 sound.
Treatment is rarely needed, if a significant shunt still exists at the ​age of 3,​ then treatment may be indicated through surgery.

  • An atrial septal defect (ASD) is an opening in one of several parts of the interatrial septum, causing a left-to-right shunt.
  • Small atrial communications often close spontaneously, but larger ones do not, causing right atrial and ventricular overload and ultimately pulmonary artery hypertension, elevated pulmonary vascular resistance, and right ventricular hypertrophy; supraventricular tachycardia, atrial flutter, or atrial fibrillation may also occur.
  • ASDs can allow emboli from the veins to enter the systemic circulation (paradoxical embolization), causing arterial occlusion (eg, stroke).
  • Auscultation typically reveals a grade 2 to 3/6 midsystolic murmur and a widely split, fixed S2; these findings may be absent in infants.
  • Moderate to large ASDs should be closed, typically between ages 2 years and 6 years, using a transcatheter device when possible.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

-Patent ductus arteriosus

A

-patent ductus arteriosus: As with foramen ovale, the ductus arteriosus is part of the fetal vasculation. It ​connects the aorta to the pulmonary artery​, allowing blood to bypass the non-functioning lungs in-utero.
Failure of the DA to close is known as ​patent ductus arteriosus​, causing a left to right shunting of blood and increasing pulmonary blood flow. PDAs account for 5-10% of all congenital heart failures.
Symptoms as always depend on the size of the shunt, however the ​big risk here is an increase in pulmonary pressure​, possibly leading to pulmonary hypertension and eventually heart failure.
Physical examination shows a widened pulse pressure, and a continuous machine-like murmur which can be heard in the left infraclavicular area. Ductus arteriosus should close within 2 days of birth.
Treatment is with ​diuretics ​initially, and then coil embolization or a PDA closure device later if required. Medication can also be used to induce constriction of a PDA, including indomethacin, ibuprofen and acetaminophen​ (paracetamol)

  • Patent ductus arteriosus (PDA) is a persistence of the fetal connection (ductus arteriosus) between the aorta and pulmonary artery after birth. In the absence of other structural heart abnormalities or elevated pulmonary vascular resistance, shunting in the PDA will be left to right (from aorta to pulmonary artery). Symptoms may include failure to thrive, poor feeding, tachycardia, and tachypnea. A continuous murmur at the upper left sternal border and bounding pulses are common. Diagnosis is by echocardiography. Administration of a cyclo-oxygenase inhibitor (ibuprofen lysine or indomethacin) with or without fluid restriction may be tried in premature infants with a significant shunt, but this therapy is not effective in term infants or older children with PDA. If the connection persists, surgical or catheter-based correction is indicated.
  • At birth, the rise in PaO2 and decline in prostaglandin concentration cause closure of the ductus arteriosus, typically beginning within the first 10 to 15 hours of life. If this normal process does not occur, the ductus arteriosus will remain patent
  • Patent ductus arteriosus (PDA) is a persistence after birth of the normal fetal connection (ductus arteriosus) between the aorta and pulmonary artery, resulting in a left-to-right shunt.
  • Manifestations depend on the size of the PDA and the age of the child, but a continuous murmur is characteristic and, if loud, has a “machinery sounding” quality.
  • Premature infants may have respiratory distress or other serious complications (eg, necrotizing enterocolitis).
  • Over time, a large shunt causes left heart enlargement, pulmonary artery hypertension, and elevated pulmonary vascular resistance, ultimately leading to Eisenmenger syndrome if untreated.
  • For premature infants with hemodynamically significant PDA, give a cyclo-oxygenase (COX) inhibitor (eg, ibuprofen lysine or indomethacin).
  • Surgical closure may benefit patients with a hemodynamically significant PDA in whom medical therapy has failed.
  • For full-term infants and older children, COX inhibitors are usually ineffective, but a catheter-delivered occlusion device or surgery typically provides long-term correction of this anomaly.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

-Tetralogy of Fallot

A

Tetralogy of Fallot consists of 4 features: a large ventricular septal defect, right ventricular outflow tract obstruction and pulmonic valve stenosis, right ventricular hypertrophy, and over-riding of the aorta. Symptoms include cyanosis, dyspnea with feeding, poor growth, and hypercyanotic “tet” spells (sudden, potentially lethal episodes of severe cyanosis). A harsh systolic murmur at the left upper sternal border with a single 2nd heart sound (S2) is common. Diagnosis is by echocardiography. Definitive treatment is surgical repair.

  • Tetralogy of Fallot involves a large ventricular septal defect (VSD), right ventricular outflow tract and pulmonary valve obstruction, and over-riding of the aorta.
  • Pulmonary blood flow is decreased, the right ventricle hypertrophies, and unoxygenated blood enters the aorta via the VSD.
  • Manifestations depend on the degree of right ventricle outflow obstruction; severely affected neonates have marked cyanosis, dyspnea with feeding, poor weight gain, and a harsh grade 3 to 5/6 systolic ejection murmur.
  • The murmur comes from the pulmonary stenosis; the VSD shunt is silent.
  • Hypercyanotic spells are sudden episodes of profound cyanosis and hypoxia that may be triggered by a fall in oxygen saturation (eg, during crying, defecating), decreased systemic vascular resistance (eg, during playing, kicking legs), or sudden tachycardia or hypovolemia. The murmur diminishes or disappears during a spell.
  • Give neonates with severe cyanosis an infusion of prostaglandin E1 to open the ductus arteriosus.
  • Place infants with hypercyanotic spells in the knee-chest position and give oxygen; sometimes, opioids (morphine or fentanyl), volume expansion, sodium bicarbonate, beta-blockers (propranolol or esmolol), or phenylephrine may help.
  • Repair surgically at 2 to 6 months or earlier if symptoms are severe.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

-Tricuspid atresia

A

Tricuspid atresia is absence of the tricuspid valve accompanied by a hypoplastic right ventricle. Associated anomalies are common and include atrial septal defect, ventricular septal defect, patent ductus arteriosus, pulmonic valve stenosis, and transposition of the great arteries. Presenting signs include cyanosis or signs of heart failure. The first heart sound (S1)is single and may be accentuated. The 2nd heart sound (S2) is usually single. Most infants have a murmur, the nature of which depends on the presence of associated anomalies. Diagnosis is by echocardiography. Cardiac catheterization may be needed. Definitive treatment is surgical repair.

  • The tricuspid valve is absent, and the right ventricle is hypoplastic; these defects are fatal unless there is an opening between the atria along with a ventricular septal defect and/or patent ductus arteriosus.
  • Infants with decreased pulmonary blood flow have progressively worsening cyanosis; infants with increased pulmonary blood flow usually have heart failure (eg, tachypnea, dyspnea with feeding, poor weight gain, diaphoresis).
  • Relieve severe cyanosis by giving prostaglandin E1 infusion to keep the ductus arteriosus open.
  • Definitive treatment requires staged operations.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

-Total anomalous pulmonary venous return

A

In total anomalous pulmonary venous return, the pulmonary veins do not connect to the left atrium. Instead, the entire pulmonary venous return enters the systemic venous circulation through one or more persistent embryologic connections. If there is no obstruction to pulmonary venous return, cyanosis is mild and patients may be minimally symptomatic. Severe obstruction of the pulmonary venous return may occur, resulting in severe neonatal cyanosis, pulmonary edema, and pulmonary hypertension. Diagnosis is by echocardiography. Surgical repair is required.

  • treatment:
  • Surgical repair
  • Medical treatment of heart failure (eg, diuretics, digoxin, angiotensin-converting enzyme inhibitors) before surgery

Neonates with total anomalous pulmonary venous return with obstruction require emergent surgical repair. In older infants, heart failure should be treated, followed by surgical repair as soon as the infant is stabilized.

Surgical repair consists of creating a wide anastomosis between the pulmonary venous confluence and the posterior wall of the left atrium. Ligation of the vein decompressing the confluence into the systemic venous circulation is important to prevent a postoperative left-to-right shunt. The repair is different for return to the coronary sinus, in which case the coronary sinus is unroofed into the left atrium and its opening to the right atrium is closed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  1. Congenital heart failure

- Newborn screening

A

Newborn screening
Manifestations of congenital heart disease may be subtle or absent in neonates, and failure or delay in detecting critical congenital heart disease, particularly in the 10 to 15% of neonates who require surgical or inpatient medical treatment in the first hours or days of life, may lead to neonatal mortality or significant morbidity.

-Universal screening for critical congenital heart disease using pulse oximetry is recommended for all neonates before hospital discharge. The screening is done when infants are ≥ 24 hours old and is considered positive if ≥ 1 of the following is present:

-Any oxygen saturation measurement is < 90%.
The oxygen saturation measurements in both the right hand and foot are < 95% on 3 separate measurements taken 1 hour apart.
-There is > 3% absolute difference between the oxygen saturation in the right hand (preductal) and foot (postductal) on 3 separate, paired measurements taken 1 hour apart.

All neonates with a positive screening result should undergo a comprehensive evaluation for congenital heart disease and other causes of hypoxemia (eg, various respiratory disorders, central nervous system depression, sepsis) typically including a chest x-ray, ECG, echocardiography, and often blood testing. Sensitivity of pulse oximetry screening is slightly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. Congenital heart failure

- Newborn screening

A

Newborn screening
Manifestations of congenital heart disease may be subtle or absent in neonates, and failure or delay in detecting critical congenital heart disease, particularly in the 10 to 15% of neonates who require surgical or inpatient medical treatment in the first hours or days of life, may lead to neonatal mortality or significant morbidity.

-Universal screening for critical congenital heart disease using pulse oximetry is recommended for all neonates before hospital discharge. The screening is done when infants are ≥ 24 hours old and is considered positive if ≥ 1 of the following is present:

-Any oxygen saturation measurement is < 90%.
The oxygen saturation measurements in both the right hand and foot are < 95% on 3 separate measurements taken 1 hour apart.
-There is > 3% absolute difference between the oxygen saturation in the right hand (preductal) and foot (postductal) on 3 separate, paired measurements taken 1 hour apart.

All neonates with a positive screening result should undergo a comprehensive evaluation for congenital heart disease and other causes of hypoxemia (eg, various respiratory disorders, central nervous system depression, sepsis) typically including a chest x-ray, ECG, echocardiography, and often blood testing. Sensitivity of pulse oximetry screening is slightly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

-Ventricular septal defect

A

-Ventricular septal defect
This is a hole between the left and right ventricle, through the ventricular septum. As the left side of the heart is always under greater pressure than the right side, blood is pushed from the left to the right. Small VSDs can be asymptomatic, but the typical finding is a pansystolic murmur​, heard best at the lower left sternal border, sometimes with a thrill. There may also be a splitting of S2 depending on the size of the shunt.
1⁄3 of VSDs will spontaneously close, ​initial treatment is diuretics with or without digoxin to reduce heart load​. If the infant continues to fail to develop, surgery may be required to close the VSD.

  • A ventricular septal defect (VSD) is an opening in the interventricular septum, causing a shunt between ventricles. Large defects result in a significant left-to-right shunt and cause dyspnea with feeding and poor growth during infancy. A loud, harsh, holosystolic murmur at the lower left sternal border is common. Recurrent respiratory infections and heart failure may develop. Diagnosis is by echocardiography. Defects may close spontaneously during infancy or require surgical repair.
  • Ventricular septal defect (VSD) is an opening in the interventricular septum, causing a left-to-right shunt.
  • Over time, large left-to-right shunts cause pulmonary artery hypertension, elevated pulmonary artery vascular resistance, right ventricular pressure overload, and right ventricular hypertrophy, which ultimately cause shunt direction to reverse, leading to Eisenmenger syndrome.
  • Larger defects cause symptoms of heart failure at age 4 to 6 weeks.

-Typically, a grade 3 to 4/6 holosystolic murmur at the lower left sternal border is audible shortly after birth.
Infants who do not respond to medical treatment of heart failure or have poor growth should have surgical repair during the first few months of life; even asymptomatic children with large VSDs should have repair during the first year of life.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Atrioventricular Septal Defect

A

-Endocardial cushion defect
Also known as atrioventricular canal defects, this is a ​complete or partial failure of the septum to fuse with the endocardial cushion causing abnormal atrioventricular valves​, a ventricular septal defect and an atrial septal defect. In effect, you end up with almost ​two chambers instead of the four​, ​connected by a pathological common valve​.
This is a very severe congenital malformation, and symptoms of ​heart failure develop due to the increased pulmonary vascular resistance within the first two months​. Treatment is diuretics (with or without digoxin) and then surgical repair which is almost always required. This defect is common in children with Down Syndrome.

  • Atrioventricular (AV) septal defect consists of an ostium primum type atrial septal defect and a common AV valve, with or without an associated inlet (AV septal type) ventricular septal defect (VSD). These defects result from maldevelopment of the endocardial cushions. Patients with no VSD component or a small VSD and good AV valve function may be asymptomatic. If there is a large VSD component or significant AV valve regurgitation, patients often have signs of heart failure, including dyspnea with feeding, poor growth, tachypnea, and diaphoresis. Heart murmurs, tachypnea, tachycardia, and hepatomegaly are common. Diagnosis is by echocardiography. Treatment is surgical repair for all but the smallest defects.
  • An atrioventricular (AV) septal defect may be complete, transitional, or partial; the majority of patients with the complete form have Down syndrome.
  • A complete AV septal defect involves a large ostium primum atrial septal defect (ASD), a ventricular septal defect (VSD), and a common AV valve (often with significant regurgitation), all resulting in a large left-to-right shunt at both atrial and ventricular levels and enlargement of all 4 cardiac chambers.
  • A partial AV septal defect also involves an ASD, but the common AV valve is partitioned into 2 separate AV orifices and there is no VSD, resulting in enlargement of the right heart chambers because of a large atrial shunt but no ventricular shunt.
  • A transitional AV septal defect involves an ostium primum ASD, a common AV valve, and a small- or moderate-size VSD.
  • Complete AV septal defect with a large left-to-right shunt causes signs of heart failure by age 4 to 6 weeks.
  • Symptoms in partial AV septal defects vary with the degree of mitral regurgitation; if mild or absent, symptoms may develop during adolescence or early adulthood, but infants with moderate or severe mitral regurgitation often have manifestations of heart failure.

-Symptoms in transitional AV septal defect fall on a spectrum, depending on the size of the VSD.
Defects are repaired surgically between age 2 to 4 months or 1 to 3 years, depending on the specific defect and severity of symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Coarctation of the Aorta

A
  • Coarctation of the aorta is a localized narrowing of the aortic lumen that results in upper-extremity hypertension, left ventricular hypertrophy, and malperfusion of the abdominal organs and lower extremities. Symptoms vary with the anomaly’s severity and range from headache, chest pain, cold extremities, fatigue, and leg claudication to fulminant heart failure and shock. A soft bruit may be heard over the coarctation site. Diagnosis is by echocardiography or by CT or MR angiography. Treatment is balloon angioplasty with stent placement, or surgical correction.
  • Coarctation of the aorta is a localized narrowing of the lumen, typically in the proximal thoracic aorta just beyond the left subclavian artery and before the opening of the ductus arteriosus.
  • Manifestations depend on severity of coarctation but typically involve pressure overload proximal to the coarctation, leading to heart failure, and hypoperfusion distal to the coarctation.
  • Severe coarctation can manifest in the neonatal period with acidosis, renal insufficiency, and shock, but mild coarctation may not be apparent until an adolescent or adult is evaluated for hypertension or diminished femoral pulses.
  • There is typically a blood pressure gradient between upper and lower extremities, an easily distinguished amplitude differential between the upper and lower extremity pulses, and a grade 2 to 3/6 ejection systolic murmur, sometimes most prominent in the left interscapular area.
  • For symptomatic neonates, infuse prostaglandin E1 to reopen the constricted ductus arteriosus.
  • Correct coarctation surgically or using balloon angioplasty with or without stent placement.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Bicuspid Aortic Valve

A
  • Bicuspid aortic valve is the presence of only two (rather than the normal three) valve cusps.
  • Patients with bicuspid aortic valve are predisposed to developing infective endocarditis, aortic regurgitation, and/or aortic stenosis. Bicuspid aortic valve can also be associated with dilation of the aortic root or ascending aorta and coarctation of the aorta.
  • Treatment is by surgical repair of stenotic valves. Regurgitant valves are treated with surgery.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Eisenmenger Syndrome

-Pulmonary vascular resistance

A

Eisenmenger syndrome is a complication of uncorrected large intra-cardiac or aortic to pulmonary artery left-to-right shunts.
-Increased pulmonary resistance may develop over time, eventually leading to severe pulmonary hypertension, bidirectional shunting with progressively increasing right-to-left shunting. Cyanosis and hypoxia inevitably lead to multiple complications discussed below. Physical findings vary depending on the underlying defect and the stage of the pathophysiologic abnormalities. Diagnosis is based on echocardiography or advanced imaging and cardiac catheterization. Once Eisenmenger syndrome occurs, the increased pulmonary vascular resistance and pulmonary hypertension are irreversible, precluding primary correction of the original defect. Therefore, treatment is generally supportive, but heart and lung transplantation may be an option when symptoms are severe. Endocarditis prophylaxis is recommended.

  • Cardiac anomalies that involve large intracardiac left-to-right shunts often eventually cause increased pulmonary resistance, which first causes bidirectional shunting and ultimately right-to-left shunting (shunt reversal).
  • With shunt reversal, deoxygenated blood enters the systemic circulation, causing hypoxia and its complications (eg, clubbing of fingers and toes, secondary polycythemia); polycythemia may cause hyperviscosity, stroke, or other thromboembolic disorders, and/or hyperuricemia.
  • Symptoms usually do not occur until age 20 to 40 years in patients with pre-tricuspid shunting; in patients with a post-tricuspid shunt, symptoms can occur during the first few years of life.
  • Symptoms include cyanosis, syncope, dyspnea during exertion, fatigue, chest pain, palpitations, atrial and ventricular arrhythmias, hemoptysis and right heart failure.
  • Doing a corrective operation for the underlying cardiac anomaly at the appropriate age should prevent Eisenmenger syndrome.
  • There is no specific treatment once the syndrome develops, other than heart and lung transplantation, but drugs that may lower pulmonary vascular resistance (eg, prostacyclin analogs, endothelin antagonists, phosphodiesterase-5 inhibitors) are useful.

Pulmonary vascular resistance is the resistance against blood flow from the pulmonary artery to the left atrium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hypoplastic Left Heart Syndrome

A

Hypoplastic left heart syndrome consists of hypoplasia of the left ventricle and ascending aorta, maldevelopment and hypoplasia of the aortic and mitral valves (frequently aortic atresia is present), an atrial septal defect, and a patent ductus arteriosus. Unless normal closure of the patent ductus arteriosus is prevented with prostaglandin infusion, cardiogenic shock and death ensue. A loud, single 2nd heart sound (S2) and nonspecific systolic murmur are common. Diagnosis is by emergency echocardiography. Definitive treatment is staged surgical correction or heart transplantation.

  • In hypoplastic left heart syndrome, there is hypoplasia of the left ventricle and ascending aorta and maldevelopment and hypoplasia of the aortic and mitral valves; an atrial septal defect and a patent ductus arteriosus are necessary for systemic blood flow (and thus immediate survival).
  • Symptoms of cardiogenic shock (eg, tachypnea, dyspnea, weak pulse, pallor, cyanosis, hypothermia, metabolic acidosis, lethargy, oliguria or anuria) appear when the ductus arteriosus begins to close during the first 24 to 48 hours of life, becoming more pronounced if supplemental oxygen is given.

-Initially, give Prostaglandin E1 to keep the ductus arteriosus open, give as little oxygen as possible (to avoid decreasing pulmonary vascular resistance and increasing pulmonary flow at the expense of systemic flow), and avoid vasoconstrictors; give sodium bicarbonate as needed.
Definitive treatment requires staged operations.

17
Q

-Truncus Arteriosus

A

Persistent truncus arteriosus occurs when, during fetal development, the primitive truncus does not divide into the pulmonary artery and aorta, resulting in a single, large, arterial trunk that overlies a large, malalignment type ventricular septal defect. Consequently, a mixture of oxygenated and deoxygenated blood enters systemic, pulmonary, and coronary circulations. Symptoms include cyanosis and heart failure, with poor feeding, diaphoresis, and tachypnea. A normal 1st heart sound (S1) and a loud, single 2nd heart sound (S2) are common; murmurs may vary. Before profound heart failure develops, peripheral pulses will be bounding because of the large run off from the proximal aorta to the pulmonary arteries. Diagnosis is by echocardiography or cardiac catheterization. Medical treatment for heart failure is typically followed by early surgical repair.

  • In persistent truncus arteriosus, the primitive truncus does not divide into the pulmonary artery and aorta, resulting in a single large arterial trunk that overlies a large ventricular septal defect (VSD).
  • Different types are distinguished based on the origin of the pulmonary arteries and associated defects.
  • Patients present with mild cyanosis, significant pulmonary overcirculation, and heart failure; a grade 2 to 4/6 systolic murmur is audible along the left sternal border and a mid-diastolic mitral flow murmur may be audible at the apex.
  • Treat heart failure with diuretics, digoxin, and ACE inhibitors; prostaglandin infusion is beneficial to maintain duct patency only in patients with type A4 truncus with interrupted aortic arch or coarctation.

Do surgical repair early; one or more revisions are usually needed as children grow.

18
Q

-Transposition of the Great Arteries

A

Transposition of the great arteries (in this case, dextro-transposition) occurs when the aorta arises directly from the right ventricle and the pulmonary artery arises from the left ventricle, resulting in independent, parallel pulmonary and systemic circulations; oxygenated blood cannot reach the body except through openings connecting the right and left sides (eg, patent foramen ovale, ventricular septal defect [VSD]). Symptoms are primarily severe neonatal cyanosis and occasionally heart failure, if there is an associated VSD. Heart sounds and murmurs vary depending on the presence of associated congenital anomalies. Diagnosis is by echocardiography. Definitive treatment is surgical repair.

  • In dextro-transposition of the great arteries (D-TGA), the aorta arises from the right ventricle and the pulmonary artery arises from the left ventricle, resulting in independent pulmonary and systemic circulations.
  • D-TGA is incompatible with life unless mixing of the circulations occurs through an atrial and/or ventricular septal opening, or a patent ductus.
  • Severe cyanosis occurs within hours of birth, followed rapidly by metabolic acidosis; there are no murmurs unless other anomalies are present.
  • Relieve cyanosis by giving prostaglandin E1 infusion to keep the ductus arteriosus open and sometimes by using a balloon catheter to enlarge the foramen ovale.
  • Do definitive surgical repair during the first week of life.
19
Q
  1. Arterial hypertension

- Definition

A

Hypertension is sustained elevation of resting systolic blood pressure, diastolic blood pressure, or both; the pressures considered abnormal in children vary based on age up to age 13. Hypertension with no known cause (primary) is most common as with adults. Hypertension with an identified cause (secondary hypertension) is relatively uncommon in children. Usually, children have no symptoms or complications of hypertension during childhood, although these may develop later. Diagnosis is by sphygmomanometry. Tests may be done to look for causes of secondary hypertension. Treatment involves lifestyle changes, drugs, and management of treatable causes.

-hypertension is a blood pressure greater than the 95th percentile for age, gender and height based on at least three different occasions

-Most hypertension in children is primary.
-Confirm diagnosis of hypertension with readings on three different visits.
-Rule out secondary causes of hypertension by physical examination and laboratory tests.
Initiate treatment with lifestyle changes, primarily diet and exercise.
-If lifestyle changes are insufficient, add drug treatment, beginning with either a calcium channel blocker or an angiotensin-converting enzyme inhibitor.
-Titrate drug dosing and drugs until optimal blood pressure is reached.

20
Q
  1. Arterial hypertension
    - Causes/etiology
    - Clinical manifestations
    - Diagnosis
    - Treatment
A

Primary hypertension
By definition, the cause of primary hypertension is not known, which is why it is a diagnosis of exclusion. However, it is known to be more common among children who
Are overweight or obese (most important risk factor for primary hypertension)
Have a family history of hypertension
-Are male
-Have a sedentary lifestyle
-Have unhealthy dietary habits (eg, high salt and calorie intake)
-Had various intrauterine factors (eg, resulting in low birth weight, prematurity, or small for gestational age)
-Have social risk factors (eg, child abuse, family and/or interpersonal violence, food and/or housing insecurity—the number, duration, and severity of these factors have a cumulative effect)

-Secondary hypertension
Secondary hypertension has an identifiable cause; the hypertension may be reversible if the cause is resolved.

The most common causes of secondary hypertension in children are
-Renal parenchymal disease (eg, glomerulonephritis, pyelonephritis, reflux nephropathy) or renal structural abnormalities (eg, obstructive uropathy, polycystic kidney disease, dysplastic kidneys)

-Renovascular disease (eg, renal artery stenosis, renal vein thrombosis)

  • Cardiovascular disease (eg, coarctation of the aorta, arteriovenous fistula)
  • Endocrine disease (eg, hyperthyroidism, mineralocorticoid excess, corticosteroid excess, catecholamine excess)

Other causes of secondary hypertension include

  • Sleep-disordered breathing
  • Neurologic causes (eg, increased intracranial pressure)
  • Drugs (eg, glucocorticoids, anabolic steroids, stimulants, oral contraceptives, nicotine, caffeine, certain illicit drugs)
  • Psychologic stress or pain
21
Q
  1. Arterial hypertension

- Treatment

A

Treatment:
Weight reduction
Dietary modification (salt and calorie reduction)
Exercise
Sometimes drug treatment
Treatment of hypertension in children includes a combination of weight reduction, diet, exercise, and sometimes drug treatment depending on the stage of hypertension. Children with stage 2 hypertension, or stage 1 hypertension with symptoms, evidence of end-organ damage, diabetes, or renal disease should be referred to a specialist to begin a more rapid and correct therapy.

Generally, drug treatment should begin with a single drug at the low end of its dosing range and increased every 1 to 4 weeks until BP is controlled, the upper end of the dosing range is approached, or adverse effects develop that affect the use of the drug. At that point, if the BP goal has not been attained, a second drug can be added and titrated as with the initial drug. Classes of oral drugs used to treat hypertension include

Adrenergic modifiers (beta- and alpha-antagonist, alpha-2-agonist, beta-blocker)
Angiotensin-converting enzyme (ACE) inhibitors
Angiotensin II receptor blockers (ARBs)
Calcium channel blockers (CCBs)
Thiazide diuretics
Vasodilators

22
Q
  1. Arterial hypertension
    - Clinical manifestations
    - Diagnosis
A

Most children are ​asymptomatic​, unless there is a secondary cause which gives symptoms. In ​severe cases, encephalopathy, heart failure, stroke and retinopathy may present​. History and family history are important to the case.

23
Q

Hypertensive Emergencies in Children

A

Hypertensive emergencies involve target organ dysfunction caused by elevated BP.
Evaluate for target organ damage using ECG, urinalysis, serum electrolytes, blood urea nitrogen, creatinine, and, if neurologic symptoms are present, CT of the head.
Admit to intensive care unit and consult a specialist in pediatric hypertension, treat with IV therapy, but do not delay treatment if these assets are not immediately available.
Preferred drugs to use include labetalol and nicardipine.
Goal of initial therapy is to lower BP to stop end-organ damage quickly but not so fast as to cause hypoperfusion.
BP should be lowered by 25% every 6 hours until the 95th percentile is approached and any related symptoms of target organ dysfunction are gone.
Children who develop a severe hypertensive emergency on top of their chronic hypertension need a more cautious approach to lowering their BP.

24
Q
  1. Inflammatory heart diseases
    - myocarditis
    - definition
A
  • Myocarditis is an inflammatory disease of the myocardium, the muscular walls of the heart, it has a broad spectrum of clinical presentations, ranging from mild symptoms to severe heart failure.
  • It can lead to diminished cardiac function and cardiac failure
  • Dilated cardiomyopathy is a complication of myocarditis and is a common indication for cardiac transplantation.
  • Myocarditis is also identified as the cause of sudden unexpected death in young patients.
25
Q

Myocarditis

-Etiology:

A
  • the etiology for myocarditis is broad it can be viral, bacterial, fungal, but can also accompany autoimmune disease, hypersensitivity reactions, and toxins
  • Viruses, account for the vast majority of pediatric myocarditis and they include influenza virus Trypanosoma cruzi (Chagas disease), adenovirus, echovirus, entrovirus, Epstein-Barr virus, hepatitis virus and so on
  • The majority of paediatric cases are believed to be due to adenoviruses and enteroviruses, such as coxsackieviruses A and B, parvovirus, echovirus, and poliovirus
26
Q

Myocarditis

  • Pathophysiology
  • three phases of viral myocarditis
A

There are several proposed mechanisms of myocardial injury in viral myocarditis.

-There are thickening and swelling of the heart muscle.

All four chambers of the heart may be affected and become enlarged.
-excessive immune-mediated destruction of the myocardium by infiltrating immune cells targeting the infected cardiomyocytes by autoimmune-mediated destruction of cardiac cells by circulating autoantibodies leading to direct virus-induced cardiac myocyte injury.

It is proposed that three phases of viral myocarditis exist, beginning with a period of

  • viral replication
  • acute injury to the myocytes,
  • evolution of dilated cardiomyopathy, associated with profound alteration in the extracellular matrix of heart muscle
27
Q

Myocarditis

-Clinical presentation

A

-Clinical presentation include
sudden death, arrhythmias, chest pain, myocardial infarction, acute heart failure with a dilated cardiomyopathy phenotype.

  • feeding difficulties, low urine output, decreased circulation, tachycardia, tachypnea Chest pain, syncope, edema hypotension and palpitations
  • Fever may or may not be present.

-Diagnosis
The diagnosis of pediatric myocarditis is especially challenging because of the variable clinical presentation, ranging from asymptomatic patients with only subtle findings on an electrocardiogram to fulminant cardiac failure and sudden death.

28
Q

Myocarditis

  • Lab findings
  • Treatment
A
  • Labs findings include
  • ECG
  • Abnormal troponin levels may support a diagnosis of myocarditis
  • An elevated creatine kinase level may also be observed in myocarditis, although it is a non-specific marker.
  • Chest X-rayfindings often include cardiomegaly and may demonstrate pulmonary oedema, infiltrates, or pleural effusions
  • ​CRP,
  • nasopharyngeal and rectal swabs,
  • lactate dehydrogenase isoenzyme 1 and Troponin 1​

-Treatment of viral myocarditis is that of minimizing the body’s hemodynamic demands, use of digoxin, diuretics and after load reduction can be useful . Immunosuppression does not seem to improve outcome.

29
Q
  1. Inflammatory heart diseases

- Pericarditis

A
  • Pericarditis is inflammation of the parietal and visceral surfaces of the pericardium , most commonly it is viral , however staphylococcus aureus and streptococcus pneumonia are the most likely causes in bacterial cases .
  • Bacterial cases are much more severe than viral cases

-Symptoms depend on the a mount of pericardial effusion
they include chest pain, dyspnea, malaise, compelled position, fever, tachycardia, friction rub, enlarged heart and distant heart sounds.

  • Where the effusion is very large there is a risk of cardiac tamponade , a condition where cardiac output is restricted due to the amount of fluid in the pericardial sac.
  • Echocardiography is the most specific and useful diagnostic test for pericarditis, and will show the classic signs of constrictive pericarditis, including a stiff or thick pericardium that constricts the heart’s normal movement.
  • while an ECG may show elevated ST and reduced QRS amplitude .
  • Treatment is pericardiocentesis if fluid has built up significantly,
  • if bacterial origin is proved then specific antibiotics can be given, but in the majority of cases which are viral, we just use supportive anti-inflammatory medications.
30
Q
  1. Inflammatory heart diseases

- Endocarditis

A

Infective endocarditis is an uncommon life-threatening condition with an incidence of about 0.1/1000 in children. Congenital heart disease is the most common underlying condition which increases the risks of endocarditis . In most cases, the condition is secondary to an indwelling central venous catheter near the heart or associated with immunosuppression .

-The most common microorganism is viridans streptococci, with S.Aureus and coagulase negative staphylococci.

  • The early symptoms are nonspecific, with fever, malaise, and weight loss . Subtle hemorrhages may also be noted under the finger nails
  • Endocarditis is usually subacute and slowly progressive, although can be acute ,secondary to sepsis .
  • Required labs include CBC, blood cultures, CRP with echo and ECG.
  • Treatment is first stabilization and supportive for cardiac failure, pulmonary edema and low cardiac output, with antibiotics given once blood cultures are obtained . High doses are required for 4-8 weeks, often penicillin G.
31
Q
  1. Heart failure
    - Definition
    - Etiology
A
  • definition: abnormality of cardiac structure or function leading to failure of the heart to deliver oxygen at a rate commensurate with the requirements of the metabolizing tissues, despite normal filling pressures
  • HF as a clinical syndrome characterized by typical symptoms and signs associated with specific circulatory, neurohormonal, and molecular abnormalities.
  • Eitology: Heart failure is caused by
  • fetal cardiomyopathies or
  • extracardiac conditions (such as sepsis, hypoglycaemia, and hypocalcaemia).

At birth, Heart failure is caused by fetal cardiomyopathies or extracardiac conditions (such as sepsis, hypoglycaemia, and hypocalcaemia).

  • In the 1st week after birth, Congenital heart diseases with ductus-dependent systemic circulation (such as severe aortic stenosis/aortic coarctation and hypoplastic left heart syndrome), in which the closure of the ductus arteriosus causes severe reduction of end-organ perfusionare the main cause.
  • In the 1st month of life, frequent causes of PHF are Congenital heart diseases with left to right shunt (such as ventricular septal defects, patent ductus arteriosus ) in which pulmonary blood flow progressively increases with the fall of pulmonary resistance.
  • Finally, HF in adolescence is rarely secondary to CHDs, but is more often related to cardiomyopathies or myocarditis
32
Q
  1. Heart failure

- Pathophysiology

A

an event produces initial reduction of cardiomyocyte contractility in HF —> reduction in cardiac output —> that the body counters by activating two major compensatory mechanisms.

The first mechanisms is the activation of the sympathetic nervous system —> increased release and decreased uptake of norepinephrine, with peripheral vasoconstriction to maintain mean arterial pressure and organ perfusion.
Enhanced catecholamine levels lead to further cardiomyocyte injury, dysfunctional intracellular signaling, and ultimately cardiomyocyte death.

The second important “compensatory” mechanism is the stimulation of the rennineangiotensin aldosterone system, consisting of increased circulating levels of renin, angiotensin II, and aldosterone. Renin is responsible of cleaving angiotensinogen in angiotensin I, which is converted into angiotensin II by the angiotensin-converting enzyme (ACE). Angiotensin II is a potent vasoconstrictor that preserves end organ perfusion.

Aldosterone causes salt and water retention, resulting in increased preload and then cardiac output, However, the elevation of both aldosterone and angiotensin II promotes cardiac fibrosis and apoptosis.
-These mechanisms may temporarily contribute to circulatory stability, but over time become maladaptive and promote the progression of HF

33
Q
  1. Heart failure
    - Clinical symptoms
    - Diagnosis
    - Treatment
A

-Clinical manifestations include: tachypnea, feeding difficulty, diaphoresis, etc., Feeding difficulty ranges from prolonged feeding time (>20 min) with decreased volume intake to frank intolerance and vomiting after feeds. Irritability with feeding, sweating, and even refusal of feeds are also common.
Established HF presents with poor weight gain and in the longer term, failure in linear growth can also result. Edema of face and limbs is very uncommon in infants and young children.
-The clinical features of HF in a newborn can be fairly nonspecific and a high index of suspicion is required. Tachycardia > 150/min, respiratory rate >50/min, gallop rhythm, and hepatomegaly are features of HF in infants. Primary cardiac arrhythmia should be considered if heart rate is more than 220/min. Duct dependent pulmonary circulation present with severe cyanosis and acidosis, whereas duct dependent systemic circulation present with HF and shock.

-Features of HF in older children and adolescents include fatigue, effort intolerance, dyspnea, orthopnea, abdominal pain, dependent edema, ascites, etc.

——-Infant and young children: The typical presentation is characterized by difficulty in feeding (from prolonged feeding time intake to frank intolerance). Cyanosis, tachypnea, sinus tachycardia, and diaphoresis can be present.
Older children and adolescence: Fatigue, shortness of breath, tachypnea, and exercise intolerance are the main symptoms. Abdominal pain, oliguria, and leg pitting edema may also be present. The severity of HF in children must be staged according to the Ross modified classification15 that recognizes four functional classes with increasing severity of clinical features from I to IV (Table 2).

34
Q
  1. Heart failure

- Diagnosis

A

-The first step in diagnostic approach in patients with PHF is based on noninvasive clinical investigations.

-6.1. Electrocardiogram
Sinus tachycardia is common in acute HF. In chronic HF, an abnormal electrocardiogram increases the likelihood of decompensated HF.16

6.2. Chest radiography
Chest radiography is indicated in all children with sus- pected HF to assess heart size and to check for other signs of HF such as pulmonary edema, septal lines (or Kerley B lines), and pleural effusions.17

-6.3. Echocardiography
The echocardiogram is the most useful, widely available, and low-cost test for patients with PHF. Echocardiography provides immediate data on cardiac morphology and structure, chamber volumes/diameters, wall thickness, ventricular systolic/diastolic function, and pulmonary pressure. These data are crucial to make the correct diagnosis and to guide appropriate treatment.18

-6.6. Cardiac catheterization
Despite advances in noninvasive diagnostic techniques, cardiac catheterization is presently indicated for20:
- accurate evaluation of pressure gradients in patients with complex valve diseases
- evaluation of hemodynamic parameters (pulmonary and systemic vascular resistance, cardiac output, and car- diac index) in Fontan patients or during pre-transplant screening


6.7. Endomyocardial biopsy
Endomyocardial biopsy is an invasive procedure with sig- nificant risk and should be performed only to confirm the clinical diagnosis of myocarditis and to choose the appro- priate therapeutic management21 (such as giant cell myocarditis).

35
Q
  1. Heart failure
    - Labs
    - Treatment
A
  • CBC: Useful to assess anemia, which may cause or aggravate heart failure. Leukocytosis may result from stress or signal an underlying infection. Hyponatremia reflects an expansion of extracellular fluid volume in the setting of a normal total body sodium.
  • Electrolytes: Hypokalemia and hypochloremia can be the result of prolonged administration of diuretics.Hyperkalemia can be the result of impaired renal perfusion and marked reductions in glomerular filtration rate or from intracellular potassium release due to impaired tissue perfusion.

-Renal function tests Liver function tests:
Elevated BUN and BUN/creatinine ratio are seen in decompensated heart failure. Congestive hepatomegaly is often associated with impaired hepatic function, which is characterized by elevation of AST, ALT, LDH, and other liver enzymes. Hyperbilirubinemia (both direct and indirect) is related to acute hepatic venous congestion and is common with severe right heart failure.
Elevated ALP, and prolongation of the PTT time can be seen.
In children with long-standing heart failure and poor nutritional status, hypoalbuminemia results from hepatic synthesis impairment.

-Natriuretic peptides (NT-proBNP/BNP):
CPK-MB, troponin I and T Lactate
Natriuretic peptides levels correlate closely with the NYHA/Ross classification of heart failure and with ventricular filling pressures.
Useful if the clinical scenario is suggestive of an ischemic process or myocarditis Elevated lactate is seen in patients with decompensated heart failure as a result of decreased tissue perfusion and/or decreased metabolism due to secondary liver dysfunction and can be a useful serologic marker for monitoring response to therapeutic interventions.

-Thyroid function tests: Both severe hyper or hypothyroidism can cause heart failure.
Usually reveal mild hypoxemia in patients who have mild-to-moderate heart failure.

-Blood glucose and serum electrolytes like calcium, phosphorous should be measured in all children with HF as their abnormalities can cause reversible ventricular dysfunction. Screening for hypoxia and sepsis should be done in newborn with HF.
Antistreptolysin O and C-reactive protein measurement should be done in cases of HF with suspected acute rheumatic fever or reactivation of chronic rheumatic heart disease. Metabolic and genetic testing may be considered in primary cardiomyopathy as recent reports suggest a genetic cause for more than 50% of patients with DCM.

36
Q
  1. Heart failure

- Treatment

A
  • Treatment of PHF aims to:
  • eliminate the causes of PHF
  • control the symptoms and disease progression.

Medical therapy for HF (Table 4) focuses on three main goals25:
- decrease of pulmonary wedge pressure
- increase of cardiac output and the improvement of end-
organ perfusion
- delay of disease progression.

Treatment:
digoxin, diuretics and afterload reduction with angiotensin-converting enzyme (ACE) inhibitors. Digoxin decreases sympathetic tone and improves growth in infants. Diuretics should be used to relieve symptoms but may not be necessary in all children.

Diureticsand angiotensin-converting enzyme inhibition are the first-line therapies, whereas beta-blockers and devices for electric therapy are less used in children than in adults. In the end-stage disease,heart transplantationis the best choice of treatment,